| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a9e6421e9257148abad101e1ce6c162 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-30 |
| filingDate |
2007-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30d792ad0cb1c0eeb747226e57ec5640
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87ebafb0e918fb66363d4ee27428d853
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6267ff214b3ee1322741bd4b5050b9cd |
| publicationDate |
2009-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
UY-30402-A1 |
| titleOfInvention |
"DERIVATIVES OF LEPTOMYCIN" |
| abstract |
Leptomycin derivatives having a group, such as a sulfide or a disulfide, that can be conjugated to a cell binding reagent as a discussed antibody. The therapeutic use of these conjugates of leptomycin derivatives is also described; these conjugates have therapeutic use because they can administer cytotoxic leptomycin derivatives to a specific cell population with a goal. |
| priorityDate |
2007-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |